Here are five highlights:
1. DUROLANE is a single-injection joint-fluid osteoarthritis treatment based on a natural, safe and proven technology process called NASHA, which yields stabilizing hyaluronic acid.
2. Hyaluronic acid is a naturally occurring molecule that provides the lubrication and cushioning in a normal joint.
3. In Taiwan, DUROLANE is indicated for the treatment of mild to moderate osteoarthritis of the knee.
4. In Taiwan, Bioventus will be working with Eulogiums, a sales and marketing leader with more than 20 years of experience in orthopedics.
5. Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely.
More articles on devices and implants:
Zacks bumps RTI Surgical down to “sell” rating: 4 things to know
Eagle Asset Management buys 1.2M+ of NuVasive stock: 4 points
Cardinal Spine files form D for $1.25M in financing: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
